AAAAAA

   
Results: 1-10 |
Results: 10
RELATIVE BIOAVAILABILITY OF NEORAL VERSUS SANDIMMUNE IN THE PRESENCE OF A P450IIIA AND P-GLYCOPROTEIN INHIBITOR
Authors: CHOC MG MUELLER EA ROBINSON WT KUMLE A SMITH HT CHARNICK SB
Citation: Mg. Choc et al., RELATIVE BIOAVAILABILITY OF NEORAL VERSUS SANDIMMUNE IN THE PRESENCE OF A P450IIIA AND P-GLYCOPROTEIN INHIBITOR, Transplantation proceedings, 30(5), 1998, pp. 1664-1665
PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF SDZ PSC-833, A NOVEL MULTIDRUG-RESISTANCE REVERSING AGENT, IN PHASE-1 TRIALS WITH CHEMOTHERAPEUTIC-AGENTS
Authors: CHARNICK SB FRACASSO P EGORIN M SONNEVELD P BLEEHAN N GIACCONE G NIEDERBERGER W SMITH HT PEARCE T SIKIC BI
Citation: Sb. Charnick et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF SDZ PSC-833, A NOVEL MULTIDRUG-RESISTANCE REVERSING AGENT, IN PHASE-1 TRIALS WITH CHEMOTHERAPEUTIC-AGENTS, European journal of cancer, 33, 1997, pp. 775-775
VALIDATION OF A LIMITED SAMPLING MODEL TO DETERMINE ETOPOSIDE AREA-UNDER-THE-CURVE
Authors: LUM BL LANE KJ SYNOLD TW GORAM A CHARNICK SB SIKIC BI
Citation: Bl. Lum et al., VALIDATION OF A LIMITED SAMPLING MODEL TO DETERMINE ETOPOSIDE AREA-UNDER-THE-CURVE, Pharmacotherapy, 17(5), 1997, pp. 887-890
DESCRIPTION OF BLOOD-PRESSURE CHANGES IN PATIENTS BEGINNING CYCLOSPORINE-A THERAPY
Authors: CHARNICK SB NEDELMAN JR CHANG CT HWANG DS JIN J MOORE MA WONG R MELIGENI J
Citation: Sb. Charnick et al., DESCRIPTION OF BLOOD-PRESSURE CHANGES IN PATIENTS BEGINNING CYCLOSPORINE-A THERAPY, Therapeutic drug monitoring, 19(1), 1997, pp. 17-24
INTERACTION OF CYCLOSPORINE DERIVATIVES WITH THE ATPASE ACTIVITY OF HUMAN P-GLYCOPROTEIN
Authors: WATANABE T KOKUBU N CHARNICK SB NAITO M TSURUO T COHEN D
Citation: T. Watanabe et al., INTERACTION OF CYCLOSPORINE DERIVATIVES WITH THE ATPASE ACTIVITY OF HUMAN P-GLYCOPROTEIN, British Journal of Pharmacology, 122(2), 1997, pp. 241-248
NEURAL-NETWORK (NN) AND LINEAR-REGRESSION LIMITED SAMPLING MODELS (LSM) FOR ETOPOSIDE (E) AUC DETERMINATIONS
Authors: LUM BL SYNOLD TW LANE K CHARNICK SB SIKIC BI
Citation: Bl. Lum et al., NEURAL-NETWORK (NN) AND LINEAR-REGRESSION LIMITED SAMPLING MODELS (LSM) FOR ETOPOSIDE (E) AUC DETERMINATIONS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 2-2
PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING AS A TOOL FOR DRUG DEVELOPMENT
Authors: CHARNICK SB KAWAI R NEDELMAN JR LEMAIRE M NIEDERBERGER W SATO H
Citation: Sb. Charnick et al., PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING AS A TOOL FOR DRUG DEVELOPMENT, Journal of pharmacokinetics and biopharmaceutics, 23(2), 1995, pp. 217-229
PK PD ANALYSIS FOR CYCLOSPORINE, MARKETED AND MICROEMULSION FORMULATIONS, IN PSORIASIS PATIENTS/
Authors: SALLAS WM MELIGENI JA CHARNICK SB
Citation: Wm. Sallas et al., PK PD ANALYSIS FOR CYCLOSPORINE, MARKETED AND MICROEMULSION FORMULATIONS, IN PSORIASIS PATIENTS/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 155-155
PHARMACOKINETICS OF SDZ-64-412, A NOVEL ANTIASTHMATIC AGENT, FOLLOWING INTRAVENOUS, ORAL, AND INHALATION DOSING IN THE RAT
Authors: CHARNICK SB YU ZL ATHILL LV KARARA AH TSE FLS LAU DTW
Citation: Sb. Charnick et al., PHARMACOKINETICS OF SDZ-64-412, A NOVEL ANTIASTHMATIC AGENT, FOLLOWING INTRAVENOUS, ORAL, AND INHALATION DOSING IN THE RAT, Biopharmaceutics & drug disposition, 15(4), 1994, pp. 317-327
THE HYDRATION OF PROTEINS IN NEARLY ANHYDROUS ORGANIC-SOLVENT SUSPENSIONS
Authors: MCMINN JH SOWA MJ CHARNICK SB PAULAITIS ME
Citation: Jh. Mcminn et al., THE HYDRATION OF PROTEINS IN NEARLY ANHYDROUS ORGANIC-SOLVENT SUSPENSIONS, Biopolymers, 33(8), 1993, pp. 1213-1224
Risultati: 1-10 |